NextCell Pharma is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Disease and Transplantation. Cellaviva, the first Swedish family saving stem cell bank, with its expertise in umbilical cord stem cells and Diamyd Medical with its interests and investments within autoimmune diseases made a natural partnership for creating NextCell Pharma. Clinical trials testing NextCell Pharma’s first product, ProTrans,has started in Novermber 2018.
#nextcellpharma #cellaviva
Biotechnology Research, Oceanography and offshore research, Research and testing, IT, Internet, R&D, Medical and pharmaceutical research, Pharmaceuticals research and development
HQ Location
Hälsovägen 7
Karolinska Institutet Science Park, Novum 8D
Huddinge, 14157, SE